About RFA

Radio frequency ablation 

A minimally invasive alternative to surgery, enabling targeted therapy and rapid recovery. Clinical evidence shows RFA can achieve complete disease resolution in selected patients.⁶ 

Clinical benefits of RFA

RFA is designed to provide safe, effective, and efficient treatment 

How RFA works 

RFA is a minimally invasive treatment method that uses an electrode to treat nodules. 

Identify and access the target nodule ³·⁴

High-resolution ultrasound imaging is used to accurately locate the target lesion 


Deliver thermal energy ²·⁴

Once positioned, the electrode emits high frequency alternating current, agitating tissue ions and generating frictional heat. 


Repeat or expand as needed ¹·⁴

Depending on lesion size or anatomy, additional ablations can be performed to cover residual regions. 



  • Where RFA is used

This content is for healthcare professionals in countries where STARMED Co. Ltd. has obtained applicable regulatory approvals. Product availability and regulatory status may vary by country. Use strictly according to approved indications, instructions, and local regulations. Please verify local regulatory status and approved uses before use.

News

Recognized in the 2025 ATA Guidelines 


Guideline update 
The American Thyroid Association (ATA) now recognizes ultrasound-guided percutaneous ablation as a potential alternative to active surveillance or surgery for selected patients with cT1aN0M0 papillary thyroid carcinoma (PTC).

Clinical relevance 
Expands treatment options for patients who wish to avoid or are unsuitable for surgery. Encourages shared decision-making, emphasizing individualized care between physician and patient. 

Source reference 
ATA Guidelines for the Management of Adult Patients with Differentiated Thyroid Cancer, 2025.


Recommendation 11: “Ultrasound-guided percutaneous ablation may be considered as an alternative to active surveillance or resection for cT1aN0M0 PTC in selected patients.” 

RFA in Action 

Reference

Reference 

  1. Michael S Lui, Kepal N Patel. Current guidelines for the application of radiofrequency ablation for thyroid nodules: a narrative review. Gland Surgery. 2024 Jan 29; 13(1):59–69. (doi: 10.21037/gs-23-18)
  2. Leba Michael Sarkis et al. A novel guided approach to radiofrequency ablation of thyroid nodules: the Toronto Sunnybrook experience. Front Endocrinol (Lausanne). 2024 Jul 24; 15:1402605. (doi: 10.3389/fendo.2024.1402605)
  3. Jae Ho Shin et al. Comparison of the Therapeutic Efficacy and Technical Outcomes between Conventional Fixed Electrodes and Adjustable Electrodes in the Radiofrequency Ablation of Benign Thyroid Nodules. Korean J Radiol. 2024 Feb; 25(2):199–209. (doi: 10.3348/kjr.2023.0577)
  4. Orloff LA, Noel JE, Stack BC Jr, et al. Radiofrequency ablation and related ultrasound-guided ablation technologies for treatment of benign and malignant thyroid disease: An international multidisciplinary consensus statement.
  5. Se Jin Cho et al. Long-Term Results of Thermal Ablation of Benign Thyroid Nodules: A Systematic Review and Meta-Analysis. Endocrinol Metab (Seoul). 2020 Jun 30; 35(2):339–350. (doi: 10.3803/EnM.2020.35.2.339)
  6. Argentesi G, Wu X, Ney A, Goodchild E, Laycock K, Lee YN, et al. Endoscopic, ultrasound-guided, radiofrequency ablation of aldosterone-producing adenomas (FABULAS): a UK, multicentre, prospective, proof-of-concept trial. Lancet. 2025;405(10479):637–647. (doi: 10.1016/S0140-6736(24)02755-7)

STARMED Co., Ltd.  I  Henry Shin
B-4th & 12th floor, Daebang Triplaon, 158, Haneulmaeul-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do, Korea, 10355 

Tel : +82 31 816 3546 I Fax : +82 31 816 4546
Email : inquiry@STARmed4u.com

copyright ⓒ STARmed Co., Ltd. All Rights Reserved.

mobile background



STARMED Co., Ltd.  I  Henry Shin
(Jungsan-dong, Daebang-Triplaon Business Tower), B-dong, 4F & 12F, 158, Haneulmaeul-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do, 10355, Korea

Tel : +82 31 816 3546 I Fax : +82 31 816 4546 I  Email : inquiry@starmed4u.com

copyright ⓒ STARMED Co., Ltd. All Rights Reserved.